comparemela.com

Latest Breaking News On - Jain vishva bharati institute - Page 1 : comparemela.com

IKS 2022: Faculty from Visva-Bharati University, Santiniketan delivered two lectures on Sanskrit and Prakrit literature at IIT Gandhinagar

Patanjali researchers were the first to published a study on 2-Deoxy-D-Glucose which is now approved by DCGI

by Bhaswati Guha Majumder - May 10, 2021 05:28 AM Yoga guru Ramdev and Patanjali CEO Balkrishna Snapshot Researchers from Patanjali Research Institute, along with experts from Vivekanand Education Society’s Institute of Technology and Jain Vishva Bharati Institute, published their findings in 2020. With the country battling the second wave of coronavirus, the Drugs Controller General of India (DCGI) on 8 May approved a drug for emergency use. The drug is 2-deoxy-D-glucose (2-DG) which has been approved as an adjunct therapy in moderate-to-severe Covid-19 cases. Being a generic molecule and analogue of glucose, it can be easily produced and made available in plenty, said the Defence Research and Development Organisation (DRDO).

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.